发明名称 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND DIMETHYL FUMARATE.
摘要 <p>This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with DMF. This invention also provides a package comprising laquinimod and DMF for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with DMF in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides a pharmaceutical composition comprising laquinimod and DMF for use in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and DMF in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.</p>
申请公布号 MX2014011616(A) 申请公布日期 2014.10.17
申请号 MX20140011616 申请日期 2013.03.26
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 KAYE JOEL FLAXMAN
分类号 A61K31/4704 主分类号 A61K31/4704
代理机构 代理人
主权项
地址